Lv P, Zhang P, Dai Y, Ge J. Understanding the circulating forms of cardiac troponin: insights for clinical practice. Clin Chem Lab Med. 2025;63(9):1667–1681. https://doi.org/10.1515/cclm-2024-1236. PMID: 40440078.

Ragusa R, Caselli C. Focus on cardiac troponin complex: From gene expression to cardiomyopathy. Genes Dis. 2024;11(6):101263. https://doi.org/10.1016/j.gendis.2024.101263. PMID: 39211905; PMCID: PMC11357864.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arifulin EA, Sheval EV. Non-Canonical Localization of Cardiac Troponins: Expanding Functions or Causing Pathologies? Int J Mol Sci. 2024;25(6):3117. https://doi.org/10.3390/ijms25063117. PMID: 38542091; PMCID: PMC10970582.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gao Y, Wang D, Mu D, Ma Y, Li Y, Qiu L, et al. Cardiac troponin. Clin Chim Acta. 2025;574:120344. https://doi.org/10.1016/j.cca.2025.120344.

Article  PubMed  CAS  Google Scholar 

Liu Y, Liu H. Prediction of chemotherapy-mediated cardiotoxicity in patients with cancer by cardiac troponin I: A systematic review and meta-analysis. Int J Risk Saf Med. 2025;36(1):26–48. Epub 2024 Nov 24. PMID: 39973426.

Article  PubMed  Google Scholar 

Michel L, Mincu RI, Mahabadi AA, Settelmeier S, Al-Rashid F, Rassaf T, et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail. 2020;22(2):350–61. https://doi.org/10.1002/ejhf.1631.

Article  PubMed  CAS  Google Scholar 

Romann SW, Giannitsis E, Frey N, Lehmann LH. Troponin Elevation in Asymptomatic Cancer Patients: Unveiling Connections and Clinical Implications. Curr Heart Fail Rep. 2024;21(6):505–14. https://doi.org/10.1007/s11897-024-00681-x. Epub 2024 Sep 10. PMID: 39254897; PMCID: PMC11511716.

Article  PubMed  PubMed Central  Google Scholar 

Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229–4361. https://doi.org/10.1093/eurheartj/ehac244. Erratum in: Eur Heart J. 2023;44(18):1621. doi: 10.1093/eurheartj/ehad196. PMID: 36017568.

Finke D, Romann SW, Heckmann MB, Hund H, Bougatf N, Kantharajah A, Katus HA, Müller OJ, Frey N, Giannitsis E, Lehmann LH. High-sensitivity cardiac troponin T determines all-cause mortality in cancer patients: a single-centre cohort study. ESC Heart Fail. 2021;8(5):3709–19. Epub 2021 Aug 15. PMID: 34396713; PMCID: PMC8497378.

Article  PubMed  PubMed Central  Google Scholar 

López-Sendón J, Álvarez-Ortega C, Zamora Auñon P, Buño Soto A, Lyon AR, Farmakis D, Cardinale D, Canales Albendea M, Feliu Batlle J, Rodríguez Rodríguez I, Rodríguez Fraga O, Albaladejo A, Mediavilla G, González-Juanatey JR, Martínez Monzonis A, Gómez, Prieto P, González-Costello J. Serrano Antolín JM, Cadenas Chamorro R, López Fernández T. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. Eur Heart J. 2020;41(18):1720–1729. https://doi.org/10.1093/eurheartj/ehaa006. PMID: 32016393.

Lehmann LH, Stein F, Jäger D, Frey N. The Heidelberg cardio-oncology unit (COUNT)-a possible blueprint for improved care of cardio-oncological patients. Clin Res Cardiol. 2022;111(2):227–9. https://doi.org/10.1007/s00392-021-01894-z. Epub 2021 Jun 28. PMID: 34181066; PMCID: PMC8817047.

Article  PubMed  CAS  Google Scholar 

Pudil R, Mueller C, Čelutkienė J, Henriksen PA, Lenihan D, Dent S, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail. 2020;22(11):1966–83. https://doi.org/10.1002/ejhf.2017.

Article  PubMed  CAS  Google Scholar 

Čelutkienė J, Pudil R, López-Fernández T, Grapsa J, Nihoyannopoulos P, Bergler-Klein J, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(9):1504–24. https://doi.org/10.1002/ejhf.1957.

Article  PubMed  CAS  Google Scholar 

Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, et al. Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis. Circulation. 2023;148(6):473–86. https://doi.org/10.1161/CIRCULATIONAHA.123.062405.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gertz MA. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. Am J Hematol. 2024;99(2):309–24. https://doi.org/10.1002/ajh.27177.

Article  PubMed  CAS  Google Scholar 

Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, Selvin E, Hoogeveen RC, Matsushita K, Nambi V, Yu B, Chen LY, Bick AG, Ebert BL, Honigberg MC, Li N, Shah A, Natarajan P, Kullo IJ, Ballantyne CM. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024;9(6):497–506. https://doi.org/10.1001/jamacardio.2024.0459. PMID: 38598228; PMCID: PMC11007653.

Article  PubMed  PubMed Central  Google Scholar 

Thavendiranathan P, Houbois C, Marwick TH, Kei T, Saha S, Runeckles K, Huang F, Shalmon T, Thorpe KE, Pezo RC, Prica A, Maze D, Abdel-Qadir H, Connelly KA, Chan J, Billia F, Power C, Hanneman K, Wintersperger BJ, Brezden-Masley C, Amir E. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines. Eur Heart J Cardiovasc Pharmacother. 2023;9(6):515–25. https://doi.org/10.1093/ehjcvp/pvad031. PMID: 37120736; PMCID: PMC10509566.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nardi-Agmon I, Di Meo A, Lam L, Kyle C, Abdel-Qadir H, Amir E, Thavendiranathan P. Circulating Macrotroponin Complexes and Their Impact on Cardiac Troponin Measurements: Potential Implications for Cardio-Oncology. JACC CardioOncol. 2024;6(4):608–11. PMID: 39239330; PMCID: PMC11372023.

Article  PubMed  PubMed Central  Google Scholar 

Kounis NG, Hung MY, de Gregorio C, Mplani V, Gogos C, Assimakopoulos SF, Plotas P, Dousdampanis P, Kouni SN, Maria A, Tsigkas G, Koniari I. Cardio-Oncoimmunology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome. Life (Basel). 2024;14(3):400. https://doi.org/10.3390/life14030400. PMID: 38541723; PMCID: PMC10971934.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kearney A, Corry N, Menown IBA. Massive Left Atrial Myxoma Presenting With Troponin-Positive Chest Pain. Cardiol Ther. 2020;9(2):577–80. https://doi.org/10.1007/s40119-020-00187-2. Epub 2020 Jul 27. PMID: 32720069; PMCID: PMC7584706.

Article  PubMed  PubMed Central  Google Scholar 

Beukema JC, Haveman JW, Langendijk JA, Oldehinkel E, van den Bergh ACM, de Haan JJ, et al. Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: a prospective cohort study. Radiother Oncol. 2024;200:110479. https://doi.org/10.1016/j.radonc.2024.110479.

Article  PubMed  CAS  Google Scholar 

Al-Hawwas M, Tsitlakidou D, Gupta N, Iliescu C, Cilingiroglu M, Marmagkiolis K. Acute Coronary Syndrome Management in Cancer Patients. Curr Oncol Rep. 2018;20(10):78. https://doi.org/10.1007/s11912-018-0724-8. PMID: 30132257.

Nardi Agmon I, Rahat O, Beigel R, Ovdat T, Habib M, Tzuman O, Bushari LI, Kornowski R, Orvin K. Short- and long-term outcomes of patients with active cancer presenting with an acute coronary syndrome. Clin Res Cardiol. 2024;113(12):1707–16. https://doi.org/10.1007/s00392-024-02438-x. Epub 2024 Mar 20. PMID: 38507056.

Article  PubMed  Google Scholar 

Totzeck M, Rassaf T. Natriuretic Peptides and Troponins: Sufficient Monitoring of Cancer Survivors? JACC CardioOncol. 2024;6(2):248–50. https://doi.org/10.1016/j.jaccao.2024.03.005. PMID: 38774019; PMCID: PMC11103026.

Article  PubMed  PubMed Central  Google Scholar 

Cronin M, Neiroukh D, Lowery A, Wijns W, Kerin M, Keane M, Blazkova S, Soliman O. Proposed framework regarding management of patients with breast cancer and anti-cancer treatment-related elevation in cardiac troponin. Int J Cardiol Heart Vasc. 2024;55:101522. PMID: 39498346; PMCID: PMC11532442.

PubMed  PubMed Central  Google Scholar 

Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, Tocchetti CG, Moslehi JJ, Groarke JD, Bergler-Klein J, Khoo V, Tan LL, Anker MS, von Haehling S, Maack C, Pudil R, Barac A, Thavendiranathan P, Ky B, Neilan TG, Belenkov Y, Rosen SD, Iakobishvili Z, Sverdlov AL, Hajjar LA, Macedo AVS, Manisty C, Ciardiello F, Farmakis D, de Boer RA, Skouri H, Suter TM, Cardinale D, Witteles RM, Fradley MG, Herrmann J, Cornell RF, Wechelaker A, Mauro MJ, Milojkovic D, de Lavallade H, Ruschitzka F, Coats AJS, Seferovic PM, Chioncel O, Thum T, Bauersachs J, Andres MS, Wright DJ, López-Fernández T, Plummer C, Lenihan D. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail. 2020;22(11):1945–60. https://doi.org/10.1002/ejhf.1920. Epub 2020 Aug 6. PMID: 32463967; PMCID: PMC8019326.

Article  PubMed  PubMed Central  Google Scholar 

Leypoldt LB, Guo L, Besemer B, Hänel M, Raab MS, Mann C, Michel CS, Reinhardt HC, Blau IW, Görner M, Ko YD, de Wit M, Salwender H, Scheid C, Graeven U, Peceny R, Staib P, Dieing A, Goldschmidt H, Bokemeyer C, Zeller T, Westermann D, Weisel KC, Twerenbold R, Beitzen-Heineke A. Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial. Cardiooncology. 2025;11(1):63. https://doi.org/10.1186/s40959-025-00358-x. PMID: 40611354; PMCID: PMC12224601.

Article  PubMed